Tobias Schmidt
Senior Vice President, Head of Discovery DISCO Pharmaceuticals
Seminars
Thursday 9th July 2026
Surface Protein Proximity Mapping Enables Logic-Gated Multispecifics for Safer, More Effective Cancer Therapies
2:30 pm
- Identifying proximal proteins on the cancer cell surface through DISCOtech, DISCOs proprietary surfaceome proteomics platform
- Leveraging DISCOtech for target pair discovery and multispecific drug development, allowing the combination of novel, proximal cancer target pairs that are mutually exclusive expressed on normal tissue
- Designing logic-gated mulitspecific ADCs and T-cell engagers, enabling the creation of ultra-clean, cancer-specific therapies
